pubmed-article:15134190 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15134190 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
pubmed-article:15134190 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
pubmed-article:15134190 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:15134190 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
pubmed-article:15134190 | lifeskim:mentions | umls-concept:C0279030 | lld:lifeskim |
pubmed-article:15134190 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
pubmed-article:15134190 | lifeskim:mentions | umls-concept:C1707478 | lld:lifeskim |
pubmed-article:15134190 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15134190 | pubmed:dateCreated | 2004-5-11 | lld:pubmed |
pubmed-article:15134190 | pubmed:abstractText | Hepatitis C virus genotype 1B responds poorly to treatment with interferon, in contrast to the more interferon-sensitive genotypes 2 and 3. Studies on combination therapy regimens with PEG-interferon and ribavirin report sustained response rates that generally do not exceed 50%, in contrast to sustained response rates of 80% for genotype 2 and 3. In Japan, a correlation was found between the number of mutations in an 'interferon sensitivity determining region' (ISDR) and outcome of interferon treatment in genotype 1B-infected patients. However, an ongoing controversy on the existence of an ISDR in non-Japanese isolates resulted, as non-Japanese studies failed to confirm this association. The present study approached this issue by carrying out a meta-analysis of ISDR sequences and response to interferon treatment. | lld:pubmed |
pubmed-article:15134190 | pubmed:language | eng | lld:pubmed |
pubmed-article:15134190 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15134190 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15134190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15134190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15134190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15134190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15134190 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15134190 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15134190 | pubmed:issn | 1359-6535 | lld:pubmed |
pubmed-article:15134190 | pubmed:author | pubmed-author:KroesAloys... | lld:pubmed |
pubmed-article:15134190 | pubmed:author | pubmed-author:SpaanWilly... | lld:pubmed |
pubmed-article:15134190 | pubmed:author | pubmed-author:SchinkelJanke... | lld:pubmed |
pubmed-article:15134190 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15134190 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:15134190 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15134190 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15134190 | pubmed:pagination | 275-86 | lld:pubmed |
pubmed-article:15134190 | pubmed:dateRevised | 2007-2-6 | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:meshHeading | pubmed-meshheading:15134190... | lld:pubmed |
pubmed-article:15134190 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15134190 | pubmed:articleTitle | Meta-analysis of mutations in the NS5A gene and hepatitis C virus resistance to interferon therapy: uniting discordant conclusions. | lld:pubmed |
pubmed-article:15134190 | pubmed:affiliation | Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. c.j.schinkel@lumc.nl | lld:pubmed |
pubmed-article:15134190 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15134190 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15134190 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15134190 | lld:pubmed |